Search Results - "Ospelt, Emma L"

138-LB: Improving Type 2 Diabetes Medication Prescribing by RIOLES, NICOLE, DESIMONE, MARISA, HESS, EMILIE J., IWUMMADU, CHINONSO V., OSPELT, EMMA L., ROMPICHERLA, SAKETH, GREENFIELD, MARGARET, TSAI, SANDRA

“…Background: For people with type 2 diabetes, implementing best practice guidelines for diabetes and cardiovascular comorbidities is important to reduce the…”
Get full text

976-P: Measuring Engagement in a National Quality Improvement Collaborative (T1DX-QI) by OSPELT, EMMA L., MUNGMODE, ANN, RIOLES, NICOLE, ROMPICHERLA, SAKETH, ODUGBESAN, ORI, HARDISON, HOLLY, ROWE, CAMPBELL, WIRSCH, ANTON, NOOR, NUDRAT, EBEKOZIEN, OSAGIE

“…Background: The T1D Exchange Quality Improvement Collaborative (T1DX-QI) is a national quality improvement network focused on improving health outcomes for…”
Get full text

1454-P: Food Insecurity in People with Type 1 Diabetes and Glycemic Outcomes by OSPELT, EMMA L., NOOR, NUDRAT, SONYA HAW, JEEHEA, HSIEH, SUSAN, WEINSTOCK, RUTH S., HANSEN, DAVID W., COSSEN, KRISTINA, FANTASIA, KATHRYN, GUTTMANN-BAUMAN, INES, RAMAN, VANDANA, SEYOUM, BERHANE, EBEKOZIEN, OSAGIE

“…Background: This multi-center study aims to explore relationships between individuals with type 1 diabetes (T1D) who are at risk for food insecurity and…”
Get full text

1042-P: Qualitative Study—Provider Awareness and Attitudes towards Type 1 Diabetes Antibody Screening by OSPELT, EMMA L., HARDISON, HOLLY, RIOLES, NICOLE, NOOR, NUDRAT, NELSON, GRACE, LEVY, CAROL J., MCKEE, ALEXIS M., ANTAL, ZOLTAN, WONG, JENISE C., OBRYNBA, KATHRYN, EBEKOZIEN, OSAGIE

“…Background: This study explores awareness and attitudes of endocrinology providers toward type 1 diabetes (T1D) autoantibody screening and identifies perceived…”
Get full text

1290-P: Diabetes Provider Perceptions of Barriers and Benefits to Type 1 Diabetes Autoantibody Screening among Patients and Relatives by OSPELT, EMMA L., HARDISON, HOLLY, RIOLES, NICOLE, NOOR, NUDRAT, CROSSEN, STEPHANIE, SMEGO, ALLISON, ALEPPO, GRAZIA, FRIEDMAN, JARED, ENG, DONNA, SULLIVAN, CATHERINE, MAJIDI, SHIDEH, LORINCZ, ILONA, EBEKOZIEN, OSAGIE

“…Background: This study highlights perceived benefits and barriers to type 1 diabetes (T1D) autoantibody screening rates in U.S. endocrinology practices…”
Get full text

971-P: Use of Telemedicine for Type 1 Diabetes Care in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) in 2021 by LEE, JOYCE M., OSPELT, EMMA L., MUNGMODE, ANN, EBEKOZIEN, OSAGIE, GUPTA, MEENAL, MALIK, FAISAL, FOGEL, NAOMI R., ACCACHA, SIHAM, HSIEH, SUSAN, WILKES, MEREDITH, NEYMAN, ANNA, VENDRAME, FRANCESCO

“…Background: The COVID-pandemic accelerated adoption of telemedicine for diabetes care in 2020. We sought to describe the utilization of telemedicine across the…”
Get full text

958-P: Associations between Effect of Body-Mass Index (BMI) and HbA1c among Children and Young Adults with Type 1 Diabetes: A U.S. Based Multicenter Study by MEKHOUBAD, ALLISON B., HSIEH, SUSAN, NOOR, NUDRAT, EBEKOZIEN, OSAGIE, ROMPICHERLA, SAKETH, OSPELT, EMMA L., ROBERTS, ALISSA J., SANCHEZ, JANINE, FERRO, DIANA, MIYAZAKI, BRIAN, LEE, JOYCE M.

“…Background: The primary objective of this U.S. based multi-center study was to examine the association of overweight and obesity with A1c levels for children…”
Get full text

834-P: Factors Associated with Optimal Glycemic Control in Children and Adolescents with Type 1 Diabetes: Real-World U.S. Multicenter Study by EBEKOZIEN, OSAGIE, NOOR, NUDRAT, SEYOUM, BERHANE, MAJIDI, SHIDEH, JONES, NANA-HAWA, MCDONOUGH, RYAN, SANCHEZ, JANINE, KIM, AHLEE, IZQUIERDO, ROBERTO, OSPELT, EMMA L., KAMBOJ, MANMOHAN K.

“…Background: Management of type 1 diabetes (T1D) involves achieving glycemic targets to avoid complications. However, despite advancements in diabetes…”
Get full text

938-P: Implementation of Psychosocial Screening in the Type 1 Diabetes Exchange Quality Improvement (T1DX-QI) Network by CORATHERS, SARAH, OSPELT, EMMA L., ROMPICHERLA, SAKETH, PRAHALAD, PRIYA, ROBERTS, ALISSA J., MUÑOZ, CYNTHIA E., BASINA, MARINA, SMITH, LAURA B., WILLIFORD, DESIREÉ N., KICHLER, JESSICA C., EBEKOZIEN, OSAGIE

“…T1DX-QI is a network of over 40 pediatric and adult centers that share best practices to improve outcomes for people with T1D. Guidelines for comprehensive…”
Get full text

136-OR: Examining New-Onset Type 1 Diabetes Educational Practices among Centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) by McDonough, Ryan, Ospelt, Emma L, Ebekozien, Osagie, Schulmeister, Caroline, Rioles, Nicole, Hardison, Holly, Plante, Deborah, Mucci, Andrea, Mathioudakis, Nestoras N, Raman, Vandana, Clements, Mark A, Collaborative, Tdx-Q

“…Background: The diagnosis of Type 1 Diabetes (T1D) requires immediate comprehensive education for people with T1D (PWD) and their caregivers. Educational…”
Get full text

1109-P: Diabetes Technology Education Processes among Centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) by Wolf, Risa M, Ospelt, Emma L, Golden, Lauren, Ebekozien, Osagie, Antal, Zoltan, Guarneri, Alissa, Steenkamp, Devin W, Nelson, Grace, Crossen, Stephanie, Kellis, Mary V, Agarwal, Shivani

“…Background: With increasing use of diabetes technologies in type 1 diabetes care, we sought to describe prescribing practices and education processes for…”
Get full text

778-P: Changes in HbA1c with GLP-1 Use in People with Type 1 Diabetes-Data from the T1D Exchange QI Initiative by Levy, Carol J, Gillis, Margaret, Gallagher, Mary Pat, Basina, Marina, Shah, Viral N, Ospelt, Emma L, Rompicherla, Saketh, Breidbart, Emily, Zupa, Margaret, Ebekozien, Osagie, Collaborative, Tdx-Qi

“…Background: Glucagon-like peptide 1 receptor agonists (GLP-1RA) are currently not approved for use in people with T1D (PwT1D). At present there is limited…”
Get full text

1293-P: Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) by Demeterco-Berggren, Carla, Jacobsen, Laura M, Guttmann-Bauman, Ines, Ospelt, Emma L, Smego, Allison, Hannon, Tamara S, Aleppo, Grazia, Choudhary, Abha, Wong, Jenise C, Ebekozien, Osagie

“…Background: The interest in type 1 diabetes (T1D) screening has been ignited since the U.S. FDA approval of teplizumab (November 2022) for the delay of T1D…”
Get full text

804-P: Understanding Off-Label Use of GLP-1 (Glucagon-Like Peptide-1 Receptor) Agonists among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) by Gallagher, Mary Pat, Basina, Marina, Ospelt, Emma L, Rioles, Nicole, Breidbart, Emily, Zupa, Margaret, Eng, Donna, Ng, Jason, Levy, Carol J, Ebekozien, Osagie

“…Background: The use of glucagon-like peptide-1 agonists (GLP-1a) as adjunctive therapy to insulin is not yet standard for people with type 1 diabetes (PwT1D)…”
Get full text